This activity is expired and is no longer available for CME credit.


Ocular Surface Diseases, Disorders, and Dysfunctions®, Volume 4, Number 2

Author(s)/Faculty: Natalie Afshari, MD, FACS; S. Barry Eiden, OD, FAAO, FSLS; Helena E. Gali, BA; Pedram Hamrah, MD, FACS; Amy Lin, MD; Milana L. Matz, OD; William B. Trattler, MD
Release Date: 11/1/2018Expiration Date: 11/1/2019
Credit Type: CME / COPENumber of Credits: 0
Content Type: MonographProvider:
Ocular surface disease (OSD) is a group of disorders commonly seen in ophthalmic practice, but it is challenging to differentially diagnose and is frequently undertreated. The consequences of undiagnosed and/or undertreated OSD can impact patient quality of life and severely affect visual acuity, especially in those undergoing cataract and/or refractive surgery. Effective diagnostics and therapeutics have been limited, but recent approvals by the US Food and Drug Administration as well as continued evaluation of new therapy modalities have the potential to enhance outcomes in patients with OSD. In this publication series, Ocular Surface Diseases, Disorders, & Dysfunctions® Volume 4, expert clinicians will review and evaluate pertinent advances in the diagnosis, management, and treatment of OSD, as well as offer clinical expertise for the management of challenging case presentations.